<DOC>
	<DOC>NCT01369459</DOC>
	<brief_summary>The goal of this project is to develop and test a brief protocol designed to systematically integrate pharmacological interventions for Attention Deficit Hyperactivity Disorder (ADHD) into behavioral treatment services for adolescent substance users with co-morbid ADHD in everyday care. Primary study aims will yield proof-of-concept data on MIP feasibility and fidelity in usual care and evidence of MIP impact on psychiatric and behavioral services utilization, medication acceptance and compliance, and satisfaction with treatment services.</brief_summary>
	<brief_title>Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Age 1317 years Caregiver able to participate in treatment One day of alcohol use to intoxication or illegal drug use in the past 30 days (or 30 days prior to living in a controlled environment) endorsement of one or more DSMIV symptoms of Substance Use or Alcohol Dependence/Abuse meet ASAM criteria for outpatient substance use treatment meet DSMIV criteria for ADHD (with or without onset prior to age 7) not enrolled in any behavioral treatment MDD Bipolar Disorder Mental Retardation PDD medical or psychiatric illness requiring hospitalization current psychotic features currently suicidal</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Comorbid</keyword>
	<keyword>ADHD</keyword>
	<keyword>SUD</keyword>
	<keyword>ASU</keyword>
</DOC>